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INTRODUCTION 
Stroke is one of the most common neurological disorders in 
clinical practice and  causing death in the developing countries as well as 
developed countries.
1
Stroke is an acute neurological injury occurring as a 
result of vascular pathological processes which manifest either as brain 
infarction or hemorrhage.  Risk factors do not explain the timing and 
activity in the occurrence of stroke. But they are helpful to prevent the 
onset of stroke by reducing the risk factors.  
 There are studies which reveal that physical activity has role in 
decreasing the Coronary events but only few for stroke. The present study 
has been designed to know whether time and activity has any significance 
in onset of the stroke and to evaluate the risk factors like alcoholism, 
smoking, Diabetes mellitus, CAHD, Systemic Hypertension, 
Dyslipidemia triggering the stroke. 
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Aim of the study 
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AIM OF THE STUDY 
 
 To find the Significance of Time in the occurrence of the 
stroke . 
 To find the Significance of activity in the occurrence of stroke. 
 To evaluate the Risk factors associated with the stroke 
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REVIEW OF LITERATURE 
 The normal function of the brain is dependent upon a relatively 
constant supply of the glucose and oxygen, which is derived from the 
blood which perfuses it i.e. 55 to 70 ml of blood per 100 gram of brain 
per minute. The principal source of the energy is almostexclusively due to 
the oxidation of the glucose. When the blood flow to the brain is critically 
reduced below 15 ml per 100 g per min, the resulting ischaemia which is 
associated with the hypoxia, when sufficiently prolonged, may cause 
death of neurons and glia resulting in the cerebral infarction. The blood 
supply to the cerebral cortex is via the anterior, middle and posterior 
cerebral arteries. 
 The mean arterial blood pressure, cerebrovascular tissue resistance, 
local metabolic products i.e.pH, PaO2, PaCO2, etc, when together with 
several known and unknown factors, helps to maintain the critical 
threshold of blood flow for the metabolism of energy. And also the blood 
flow varies in different areas of the brain and a self regulatory mechanism 
i.e. the auto-regulation determines the regional flow to meet local 
metabolic needs. 
 In the regions of the cerebral ischaemia, there is loss of the 
autoregulation and the microvasculature becomes non-reactive to the 
pressure changes, to the vasoactive agents and also to the other forms of 
the stimuli. The cerebral vasculature in these ischaemic zones becomes 
7 
 
permeable to the proteins and the fluid leaking in the vicinity resulting in 
the extracellular cerebral oedema. Such vascular events can also lead to 
the local haemoconcentration and the vascular stasis. 
 There are some mechanism for protecting the brain from the 
ischemia. One such way is by the several collateral pathways which 
exists. The vertebral arteries and the four major extracranial arteries 
forms a good calibre, low resistance anastomosis which is the circle of 
Willis. In addition to it, extracranial anastomosis exists between the 
cervical branches of the ipsilateral external carotid, subclavian and 
vertebral arteries. These arterial anastomosis helps to maintain the 
cerebral blood supply even with the occlusion of major arteries and 
various cerbellar arteries. These post-Willisian anastomosis further 
protect cerebral tissue from the effects of occlusion of single cortical 
branches. 
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 In the presence of generalised arterial disease like atherosclerosis, 
congenital variations and also in the presence of multiple skipped stenotic 
lesions, these collateral pathways may prove inadequate and they will 
predispose to the cerebral ischaemia or infarction. 
 When for any reasons like, such as cardiac arrest or prolonged 
hypotension (systolic BP below 70 mmHg), the brain tissue will be 
significantly deprived of its nutrition for more than three minutes, 
cerebral infarction will occur. Such infarcts will either be pale (ischaemic 
infarction in thrombosis) or it may show petechial haemorrhages in the 
cortical mantle (haemorrhagic infarction in embolism). The sylvian 
region is commonly involved in middle cerebral artery occlusion (mid-
field infarct), whereas with internal carotid artery lesions, the cerebral 
infarction is mostly located in the distal water territory (end-field 
infarction). 
A mid-field infarct is usually produced by the occlusion of a small 
penetrating vessel, and if located in the territory of a major anatomical 
pathway, it may prove catastrophic. An end-field infarct resulting from 
occlusion of a major vessel in the neck with good collateral circulation 
may be asymptomatic. Obstruction to venous return can also result in 
haemorrhagic infarction (e.g. cerebral venous thrombosis). 
 Acutely infarcted brain tissue is always soft and swollen, it 
frequently herniates downwards and it may compress the vital centres 
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within the brainstem, ending in a fatal outcome. Like infarction elsewhere 
in the body, cerebral infarct also heals by fibrosis. It is frequently 
replaced by a firm scar or a cystic cavity. 
 Cerebral infarction is mainly attributed to the partial or total 
occlusion of its regional microvasculature by thromboembolism. Cerebral 
atheroma is by far the most common underlying intimal vascular 
pathology. Thrombosis associated with arteritis like syphilitic, 
tuberculous, etc. is not an uncommon aetiology for the strokes in the 
young patients in India. 
 Recent studies have shown that there is a dense central core, 
surrounded by a less dense zone of ischaemia which is called as 
penumbra, and the neuronal death occurs in this focus unless perfusion is 
quickly restored to it. On the other hand, when the cells in the zone of 
penumbra remain viable for at least three hours i.e. the therapeutic 
window, then it can be salvaged by reperfusion with or without 
neuroprotective agents. Major factors which will enhance the nerve cell 
injury are, an increase in the intracellular cytosolic calcium concentration 
from the failure of ionic pump functions or leaks, and the changes in 
Na+/K+ gradients, acidosis, the release of free radicals, and some other 
unknown factors, which in turn disrupt the blood-brain barrier (BBB) and 
also the microvascular function. Here, energy depletion from brain 
hypoxia is one of the key events that fails to maintain normal 
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concentrations of cellular adenosine triphosphate (ATP), which leads to 
the delay in resynthesis of macromolecular proteins, which is essential for 
the cell structure. Such energy failures will also induce proteolysis and 
lipolysis in addition to production of arachidonic acid and platelet 
activating factors, free radicals, etc., thus resulting in further neuronal 
damage i.e. the ischaemic cascade. Thus, the severity of cerebral infarct is 
not the mere result of ischaemia from occluded vessels but the end-result 
of several highly complex ischaemia-modifying factors. 
 Internal carotid artery syndrome can occur in the thrombotic stroke. 
The common site for thrombotic occlusion is the cervical portion of the 
internal carotid artery near the carotid sinus. Almost 1/3rd of the occlusive 
lesions are located in this segment. Most of these lesions can be silent or 
asymptomatic because enough blood reach the affected territory via the 
external carotid ophthalmic anastomosis or from  the superficial and deep 
cervical anastomoses or from the opposite carotid artery through the 
anterior segment of the circle of Willis. 
 In the patients with symptomatic carotid thrombosis, warning 
symptoms usually will occur before the main insult in majority of the 
patients. These patients present with the symptoms of brief episodes of 
confusion, difficulty with speech which can be aphasia or dysarthria or 
dyslexia and even sensory paraesthesia, with or without motor weakness 
of the opposite side. Ipsilateral (same side) transient monocular blindness 
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(amaurosis fugax), fleeting or semipermanent, alternating with or can be 
accompanied by a contralateral hemiplegia or asensory deficit, is the 
pathognomonic of carotid artery syndrome. 
 The patients with acute carotid occlusion present in the similar 
fashion as the patients with the  middle cerebral syndrome. On 
examination of these patients , some features like the feeble pulsations of 
the internal carotid artery or superficial temporal artery, dilated pupil and 
poorly pulsating retinal vessels with or without optic atrophy on the side 
of the suspected carotid lesion, and ocular or cervical bruits on the 
ipsilateral side, may suggest the correct diagnosis. Carotid Doppler 
sonography and angiography are helpful in the  diagnosis and also to find 
the degree of stenosis and also to determine the collateral flow. 
 The patients with an old or silent occlusive carotid artery lesion on 
one side, with a new lesion on the oppostie side may prove catastrophic. 
Here, the patients present with the physical finding of bilateral 
hemiplegia (quadriplegia) with coma which can even be mistaken for 
basilar artery syndrome. 
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Major Risk factors for stroke are 
 Old age 
 Obesity 
 Hypertension 
 Smoking  
 Diabetes mellitus 
 Atrial fibrillation 
 Heart disease 
 Dyslipidemia 
 Hyperfibrinogenemia 
 Alcohol 
 Coagulopathy 
 Contraceptive pill 
 Markers of arterial atheroma (TIA, Angina, Claudication, Bruit) 
Old age is very important risk factor . As age advances the risk 
of stroke increases . Male Hypertensive old patients are more 
vulnerable than female patients. All the risk factors usually 
accelerates the atherosclerosis and then causing thrombosis and 
stroke. 
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Normal BP <120mmHg/<80mmHg 
Pre Hypertension 120-139mmHg/80-89mmHg 
Stage I hypertension 140-159mmHg/90-99mmHg 
Stage II hypertension >160/>100mmHg 
Isolated hypertension >140mmHg / <90 mmHg 
 
 Hypertension is a modifiable risk factor in stroke. It usually 
accelerates atherosclerosis and causes stroke. Isolated systolic 
hypertension is much more dangerous risk factor. BP control helps to 
prevent the recurrent stroke. Blood pressure treatment, resulting in a 
reduction in SBP of 10-12 mm Hg and 5-6 mm Hg diastolic, is associated 
with a 38% reduction in stroke incidence.
2
 When hypertension is 
controlled it reduces the atherosclerosis progression thus reducing the 
progression rate of stenosis of major vessels. 
 Diabetes mellitus which is Fasting blood sugar >126 mg% and 
PP>200mg% or RBS>200 mg% with symptoms of diabetes is also an 
important risk factor in stroke. Diabetes can cause acute complications, 
microvascular complications and macrovascular complications. 
Macrovascular complications are stroke, coronary artery disease and 
peripheral artery disease. When diabetes is present with hypertension, it 
increases the more chances of Coronary artery disease, by accelerating 
the atherosclerosis and thus it increases the chances of stroke. So diabetes 
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and hypertension must be controlled. Increased insulin levels are 
associated with atherosclerosis. When the microvascular complications of 
diabetes are present like retinopathy, neuropathy and nephropathy, pt is 
more susceptible for stroke. 
 Dyslipidemia are important risk factor in stroke. They can be 
elevated TGL levels, cholesterol levels, LDL levels or decreased HDL 
level. Dyslipidemia accelerates the atherosclerosis causing stroke. Statins 
has been well established to reduce the ischemic stroke. LIPID study 
showed reduction in stroke . 
 Atrial fibrillation can be due to lone atrial fibrillation, 
hyperthyroidism, valvular heart disease, alcohol, cardiomyopathy. Atrial 
fibrillation is an important risk factor in stroke .As the age advances the 
AF rate increases. It causes embolic stroke. AF increases the mortality in 
patients. Patient will need both rate and rhythm control. For 
hemodynamically stable AF patients, drugs are needed and for unstable 
patient, a DC shock is usually needed. Anticoagulants are also needed in 
AF patients to maintain a INR ratio  of 2 – 3. When patients with no 
structural heart disease present with AF, it is called as lone AF. 
 Smoking increases the atherosclerosis, it usually depletes the 
antioxidants like proteases. Thus it will prevent the protective mechanism 
action against preventing atherosclerosis and thus increasing the risk of 
stroke. Cigar or pipe smoking is very dangerous, Beedi and also cigarette 
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smoking are dangerous. Smoking also causes the spasm of the coronary 
vessels. Smoking can cause hypoxia. Smoking also increases the risk of 
many malignancies including lung cancer. Patient has to counseled about 
the ill effects of smoking and advised to quit the smoking. Some patients 
who are not able to quit smoking due to irresistible desire to smoke can 
be give nicotine replacement therapies.Patient can also be given 
antianxiety drugs like buprioprion. 
 Alcohol is usually protective when taken in mild quantity as it 
increases the good cholesterol HDL. When taken in moderate and large 
quantities it is harmful as it increases the LDL and decreases the HDL 
thus favouring the atherosclerosis. It can cause atrial fibrillation and can 
cause stroke. It can cause hypertension and even hemorrhagic stroke. So 
alcohol consumption should be avoided. Heavy drinkers should be given 
counseling for quitting alcohol. They can be treated with antianxiety 
drugs. Alcoholic anonyms are present in various parts of the country 
which helps the patients to quit from alcohol. 
Carotid artery stenosis when greater than 75 % is an important risk factor 
in stroke. TIAs are important risk factor in stroke. TIA is one in which 
focal neurological defecit usually resolves within 24 hours. 
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TIA can be of 3 types 
1. Low flow TIAs – atherosclerotic lesion at ICA, MCA or at junction 
of vertebral with basilar arteries 
2. Embolic TIAs – usually single. 
3. Lacunar TIAs – due to lipohyalinosis in response to atheroma or 
hypertension. 
  Recurrent stroke have high mortality rate. 
 Some unusual causes of stroke are Marfan, marantic endocarditis, 
moyamoya disease, MELAS, HIV, Collagen vascular disease, arterial 
dissection, syphilis, fabry disease, scleroderma, arterial dissection, drugs, 
hanging, cervical radiation. 
Hematological causes of stroke are  
 Polycythemia 
 Thrombocythemia 
 TTP 
 Sickle cell disease 
 PNH 
 Lupus anticoagulant 
 Protein C deficiency 
 Protein S deficiency 
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 Antithrombin III deficiency 
 Leukemia 
 Homocysteinemias 
 Elevated Homocysteine is associated with increased risk for stroke. 
 Homocysteine metabolism usually requires vitamin B6, folic acid 
and vitamin B12. Increased homocysteine levels are seen in patients with 
deficiency of folic acid, vitamin B6 and B12. It has been found to 
increase the cardiovascular risk and thus increasing the stroke. Its level 
can be reduced by giving vitamins B6, B12 and folic acid. 
 Hematological factors should be looked in young stroke patients 
which is defined as patients with stroke onset before the age of 40 years. 
Protein C deficiency, protein S deficiency, anti thrombin III mutation 
have increased risk for thrombosis thus increasing the risk of stroke. 
 Antiphospholid antibody syndrome are associated with increased 
risk of stroke. 
 Antiphospholipid antibodies (aPL) are acquired antibodies present 
in circulation which can be either a). lupus anticoagulant (LAC) and         
b). anticardiolipin antibodies (ACA). 
 The antibodies may belong to the IgG or IgM classes.LAC is 
detected by coagulation assays. LAC leads to prolongation of PTT which 
is the screening test 
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The clinical manifestations are  
 
Major manifestations : Venous thrombosis 
 
Arterial thrombosis 
 Recurrent foetal loss manifesting as second or 
first trimester abortions or intrauterine foetal 
death and thrombocytopenia. 
Minor features: Coomb’s positive haemolytic 
 anaemia, skin lesions such as  
 livedoreticularis.  
 Neurological lesions : TIAs and strokes 
 Heart valve lesions : Verrucous 
 endocarditis, coronary artery  
 disease and catastrophic APS. 
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 Anti phospholipid antibody syndrome can be treated with 
antiplatelet drugs, immunosuppressants and even plasmapheresis is tried 
in many patients. 
 In TTP, usually in majority of the patients there is no aggravating 
cause. It is due to the deficiency or antibodies to ADAMTS13. It can be 
inherited ( Upshaw Shulman) or acquired abnormality due to HIV, 
pregnancy, cancer, antiplatelet drugs.The condition includes  by renal 
dysfunction, microangiopathic hemolytic anemia, fever, central nervous 
system abnormalities, and thrombocytopenia.  
 Jaundice can be seen. Females are more commonly affected.  The 
neurological features can includecoma, convulsions,headache, confusion, 
delirium and focal neurological deficits. The presence of coombs negative 
hemolytic anemia, fragmented RBCs in peripheral smear, 
thrombocytopenia confirms the diagnosis. It is usually treated by 
corticosteroids, platelet aggregator inhibitors, exchange Transfusion. 
Von will brand is the most common hereditary bleeding disorder. It 
is characterized by prolonged bleeding time, decreased factor VIII level 
and reduced level of VWF. It is associated with increased risk for stroke. 
Desmopressin increases the VWF level and it is used for treatment of 
VWF. Other treatment includes cryoprecipitate, platelet transfusions and 
Fresh frozen plasma. 
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The term polycythaemia denotes increase in the total number and 
volume of RBCS. Polycythaemiacan be either absolute or relative. It is 
absolute when either No. of RBCs is increased or when plasma volume 
alone is decreased. Primary polycythaemia vera is an absolute increase in 
RBC mass due to   neoplastic proliferation of erythroid elements. The 
erythroid proliferation is not due to increase in erythropoietin levels 
although the erythroid tissue still retains its  capacity to respond to 
erythropoietin. Secondary polycythaemia often results from increased 
erythropoietin activity caused by hypoxia  like high altitude, lung 
disorder, smoking, cyanotic congenital heart disease, carbon monoxide 
toxicity, sleep apnoea syndrome or abnormal and inappropriate secretion 
of erythropoietin by neoplasm of kidney, liver, lung, uterus and 
cerebellum. Drugs can also lead to mild or moderate increase in 
erythrocyte numbers.Haemoconcentration by any cause can leads to 
relative increase in erythrocyte numbers and volume in a given unit of 
blood. This is termed relative polycythaemia. 
In this condition there is no rise in number or volume of total 
erythrocytes. Polycythemia is a well established risk factor in stroke. 
Polycythemia causes hyperviscosity then reducing the blood flow to the 
brain and thus they cause more chance of stasis of blood and thrombosis 
and thus causing stroke. They can cause ischemic stroke and cerebro 
vascular thrombosis. Most common neurological manifestations are 
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headache followed by vertigo followed by TIA followed by ischemic 
stroke. Anticoagulants are usually prescribed for it . 
Leukemia usually causes stroke  by meningeal spread. Patients 
may present with headache, vomiting, vertigo, nausea, hydrocephalus, 
encephalopathy, cranial neuropathy, radiculopathy, seizures 
or myelopathy. Leukemia can also cause SOL ( space occupying lesion). 
It involves cerebral hemisphere more than cerebellum, brainstem and 
spinal cord which can also be involved. Symptoms are due to the site of 
SOL and depend on the rate of growth of SOL.AML can manifest in the 
central nervous system as a extramedullary manifestation which is 
called as Chloroma (granulocytic sarcoma). 
Chronic lymphocytic leukemia can involve the brain by the 
development of  NHL which is called as Richter syndrome. . 
Leukemia can cause ischemic CVA and Hemorrhagic  CVA. It can 
cause vasculitis and which can cause stroke. Hairy cell leukemia has 
been reported with CVA. Drugs used in leukemia can also cause CVA. 
Posterior reversible encephalopathy syndrome is a form of 
Hypertensive encephalopathy seen in leukemia. It is usually reversible 
but sometimes it can lead to deformity. Leukemia patients are more  
prone for CNS infections. 
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Estrogen has been both cardio and neuroprotective. But its role in 
prevention of stroke in postmenopausal women is controversial. Some 
studies reveal it increases risk of stroke in post menopausal woman. 
Some studies reveal it does not decrease the risk of stroke. Raloxifene 
and tamoxifen increases the risk of CVA . So these drugs cannot be used 
as prophylaxis for prevention of stroke. 
   Oral contraceptives have been associated with increased risk of 
CVA and CVT. Pregnancy is also a risk factor of CVT. When OCP 
usage is associated with hematological abnormalities which can cause 
thrombosis then the risk of CVA increases. 
 Depression can also cause stroke. Depression has also been 
related to increased cardiovascular events. Treatment includes 
antidepressants. 
Diet which includes increased salt intake will cause hypertension 
and then it will increase the risk for stroke. So diet with low salt i.e. low 
sodium and high potassium should be given. DASH diet                           
(dietary approach to stop hypertension) includes low salt, high 
potassium, calcium, magnesium, low nonfat diary products, fruits and 
vegetables.  
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This diet has shown to reduce the hypertension and decrease the 
risk of stroke and also seen to cause weight loss. Physical inactivity can 
lead to obesity, metabolic syndrome, HT and can increase the risk of 
stroke. Physical activity is advised to decreased all the risk factors. It 
should include exercise 30 minutes atleast 5 days a week. Physical 
activity has lot of beneficial effects.  
Obesity is defined as BMI more than 30. Obesity has increased 
risk of stroke by increasing other diseases like diabetes. So weight 
control is advised. 
Regular physical activity and healthy life style and balanced diet 
is advised. For moribund obesity there are bariatic surgeries available. 
Cerebral embolism is the local occlusion of an intracranial artery by a 
circulating fragment, which may be composed of broken bits of thrombi, 
platelet-fibrin masses, cholesterol debris, tumour cells, fat globules, gas 
bubbles, bacteria and parasites or other foreign bodies. Atrial fibrillation 
is the commonest cause. Then atheroma of the great arteries is the next 
cause. Atrial fibrillation causes stroke by sudden dislodge of the 
thrombus in the cardiac chamber or vegetations in the cardiac chamber. 
Thrombosed pulmonary veins in lung abscess, empyema and purulent 
lung infections are also causes. Sometimes Recurrent embolic stroke can 
occur due to SABE, NBTE and atrial myxoma. Most commonly they 
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involve middle cerebral artery. They can cause RIND which is defined 
as neurological defecit which completely resolves within a period of 1 – 
3 weeks. Usually embolic stroke are sudden in onset with maximum 
defecit at onset because enough time is not there for protective 
mechanisms to protect the brain from ischemia. When this embolus 
occlusion breaks away, circulation is restored in the infarct zone and 
patient recovers. 
 General physical examination reveals murmur, arrhythmia, 
hypotension and patient can complain of syncope, palpitation, angina, 
dyspnoea. Ophthalmoscope examination can show may embolic segment 
in the retinal vessels .Pt may present with fever. 
There are no warning signs or symptoms before the onset of stroke. 
The stroke is usually complete at onset developing within seconds or 
minutes but sometime patient can have stuttering onset too. The clinical 
feature vary with the site of involvement in brain, and the syndromes 
occur according to the sites of involvement in brain and thus they can 
resemble like thrombotic stroke.Massive infarct can present even as 
coma. 
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Bad prognosis in Embolic stroke are 
 coma at the onset of the stroke 
 fever 
 intercurrent infections 
 cardiac disease 
 HT 
 DM 
 Advancing age 
 Embolism in the basilar artery 
 Nearly 30 per cent of all patients with first embolic stroke die from 
the first attack and almost 80 per cent of coma patients succumb to the 
stroke.Patients in embolic stroke surviving the acute insult, recovery 
occurs. Recurrence is common in embolic stroke and 40 % die from the 
second attack. 
 Laboratory findings are similar to that of the thrombotic stroke. In 
septic infarct, WBC count is increased and in haemorrhagic stroke, there 
is blood stained CSF . Atrial fibrillation, atrial flutter, arrhythmia , ECG 
abnormalities, cardiomyopathy can be seen. Angiographic studies reveal 
the occlusion in cerebral arteries which are usually migratory and when 
repeated the studies few days later, occlusion is not seen which reveals 
the vanishing emboli. 2-D echo or transoesophagealechocardiography 
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helps to find the intracardiac and valvular abnormalities present in the 
heart and detailed cardiovascular evaluation by newer imaging techniques 
like MRI, PET scan can be useful. 
Embolic stroke can be diagnosed by : 
 clinical history of sudden onset of complete stroke within few 
minutes 
 absence of warning symptoms 
 presence of potential source of embolism 
 evidence of previous or concurrent episode of embolism to 
other parts of the body 
 clear CSF  
 Nursing care and medical care are the mainstay of the therapy. 
There is no role for vasodilators. Anticoagulants are of little help. In 
Massive infarction or in presence of Hypertension, anticoagulants are not 
given to the patient. Long-term anticoagulant treatment is given to 
patients with irregular tachyarrythmia to prevent recurrent embolism. 
Treat the cause of embolic stroke. Active rehabilitation should be given to 
the patient. Antiarrythmics should be given according to the arrhythmia 
present in the patient. Surgical treatment can be rewarding in atrial 
fibrillation and in removal of embolus from the cardiac chamber. 
Infective endocarditis should be treated with the antibiotics according to 
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the organism present and duration of the therapy should be as advised 
according to organism and its resistance. 
 In Atrial fibrillation, the heart rate is irregularly irregular and atrial 
fibrillation is due to uncoordinated  activation of the atria occurying 
irregularly. Many of the rapid atrial impulses are blocked by the A-V 
node. Some impulses however pass through and activate the ventricles. 
Concealed conduction may occur in addition. 
 Atrial fibrillation may be paroxysmal or persistent. In lone atrial 
fibrillation, no organic cause can be detected. Atrial fibrillation can also 
occur in tachybrady syndrome, which occurs  in sick sinus disease. 
Chronic  AF is usually seen in the tropics in patients with  RHD, 
especially mitral stenosis, IHD, thyrotoxicosis, cardiomyopathy, chronic 
obstructive lung disease, ASD and post-operatively  
Causes of atrial fibrillation are 
1. mitral stenosis due to rheumatic etiology 
2. thyrotoxicosis 
3. IHD 
4. SN dysfunction 
5. Cardiomyopathy 
6. Alcohol 
7. Myocarditis 
8. HT 
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9. Pericarditis 
10. CHD 
 The ventricular response is very fast and it can be stopped  by 
digitalis. Verapamil and diltiazem act as a brake in AV node and thus 
help to decrease the rate. DC shock can be given in hemodynamically 
unstable AF. Normal sinus rhythm may be restored with quinidine,. 
Procainamide can also be given but usually large doses may be necessary. 
Propranolol and verapamil are given when the ventricular rate is very 
rapid. In resistant patients amiodarone may be tried. 
 Long-term anticoagulation have to be given to the patient as it will 
help in preventing the thromboembolic episodes. Before the elective 
conversion of AF, the patient have to be administered anticoagulants for 
some period of time. 
Haemorrhagic strokes can occur due to the following reasons 
1. HT cerebral haemorrhage 
2. Ruptured cerebral aneurysm which can be saccular, mycotic, etc.  
3. Ruptured angioma which can be either arterial, venous or mixed  
4. Trauma  
5. Blood dyscrasias like  purpura, hyper viscosities syndrome, 
bleeding diathesis, leukemias 
6. due to anticoagulants of  when the pt is put on anticoagulant therapy  
7.  Brain tumours which can cause bleeding 
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8. other  causes like arteritis, bleeding in haemorrhagic infarct. 
9.unknown cause 
In Hypertensive hemorrhagic CVA, Spontaneous intracerebral bleeding 
occur from smallblood vessels like arterioles, capillaries or venules in 
severely hypertensive individuals. 
 Haemorrhagic stroke occurs in almost 20 % of all strokes and 
aincidence increases as the age advances and most of the individuals in 
hypertensive patients from 55 to 75 years of ageare usually of the  
primary intracerebral haemorrhage type. Males and females are usually 
equally affected. Hypertension can be primary or secondary. 
Site of haemorrhages are usually supratentorial in location in the cerebral 
hemispheres of about 4/5th, the remainder 1/5this in the posterior fossa in 
the brain. The  order of frequency of ICH according to the location are as 
follows,  
 putamen and internal capsule, often extending into the central 
white matter  
 thalamic-subthalamic region 
 cerebellum   
 pons . 
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 Hypertensive CVA are usually not seen in the cerebral white 
matter. The source of haemorrhage is not usually seen can be which can 
be, from small vessels. The blood whichflows under high arterial 
tension,usually dissects the brain parenchyma,it causes the  physical 
disruption of the brain tissue, the bleeding source is either not seen or 
destroyed. Finally it will find its way into the ventricular system and 
subarachnoid space and sothe CSF becomes bloody. Signs of raised ICT 
can also be seen in the patients. Usually haematomatas which are large, 
seen in the supratentorial location, displaces the midline structures,and 
also it can interfere with the venous drainage in the midbrain. The 
prognosis in the brainstem haemorrhages which causes  obstruction to the 
venous drainage system is usually lethal. 
Patients with hematoma which are small in size have a better 
prognosis, egthalamic  hematoma of size < 2.5 cms. 
Usually these hematomas can be slowly resorped over a period of  
8 to 24 weeks and then they can be  finally replaced by a chocolate-
coloured cystic cavity, or  cleft lined with as troglial scar tissue and also 
haemosiderin-laden macrophages. 
The hypertensive individuals can present withplethora; Usually 
they present with a blood pressure higher than 160 mmHg SBPand 100 
mmHg DBP. Other signs revealing  hypertensive retinopathy can be seen 
in the patients, while papilloedema can be seen in the patients who 
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present with malignant hypertension. Concentric LVH is not found 
routinely in the patients. In patients presenting with features of secondary 
hypertension, signs of the cause of the disease can be seen. 
Usually there is no prodromal symptoms in these patients. 
Sometimes when the patient is carrying out some physical activity, the 
patient suddenly develops the  headache and sooner usually within 30 
minutes, patient  develops the signs of focal neurological deficit. After 
sometime ( few hours), the headache disappears rapidly. Finally the 
patients presents with areflexia, flaccidity, sensory paralysis or amotor 
paralysis or combination of both with or without coma. 
In the patients who develop  putamen and capsular haemorrhage, 
patient strong deviation of conjugate lateral gaze, and the head to  the side 
of the  lesion in brain, with contralateral side hemiplegia. Some patients 
develop few signs  ofthe middle cerebral artery syndrome. 
Patients who present with the same side (ipsilateral) dilated pupil, 
with contralateral hemiplegia, is suggestive of cerebral edema with 
herniation and the prognosis is usually very bad and in many cases death. 
The patients who develop thalamic haemorrhage, the signs of 
sensory deficit usually predominate than the motor paralysis 
(hemiplegia). In these patients usually eyes reveal several abnormal 
findings. These can be either a paralysis of vertical gaze, or a  downward 
deviation of the eyes or even absence of convergence with intact lateral 
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gaze or a skew deviation of the eyes or a small non-reactive pupil on the 
side of the haematoma or even a retraction nystagmus. Patients can be 
aphasic, and may reveal many signs such as agnosia, homonymous 
hemianopia, hallucinosis and mutism. The patient is usually alert or 
lethargic and survival from the lesion is common. 
The patients who have pontine haemorrhages, coma is the initial 
presentation itself and signs of paraplegia or quadriplegia (bilateral 
sensory-motor deficit) can be seen. During the initial stages, patient can 
present with  paralysis of lateral rectus muscle (lateral movements – 
abduction), these movements can be even absent to caloric stimulation, 
but as the time progresses the eyes finally do not show any movement in 
any direction (fixed gaze). Patients show pin-point pupils which have 
very sluggish reaction to the bright source of light. When the patients 
have haematoma in this site, it is always fatal. 
Patient with cerebellar haemorrhage, the initial presentation is 
usually an intense occipital pain, vertigo and they vomit quite often. 
Patients are usuallyalert at the onset of the stroke, but they are unable to 
maintain an upright balance in sitting or standing or walking. The unusual 
feature of these patients are lack of the ataxic signs in the limbs and 
syndromes are usually never seen. The patient can present with a 
quadriplegia when the haematomais compressing the pons, apontine 
syndrome can be seen in these settings. The patients can present with the 
34 
 
paralysis of lateral gaze to the side of the lesion in the brain or a forced 
lateral gaze deviation to the opposite side of lesion in the brain. The 
patients have usually sparing of their vertical gaze. Patients have  small 
pupils which are usually reactive to light until late in the disease. Neck 
retraction can also be seen in these patients. 
The laboratory findings in the ICH is sanguinous CSF which 
confirms the diagnosis. The fluid is uniformly blood-stained and it does 
not clot on standing and the supernatant fluid shows xanthochromia. The 
leucocyte count (WBC) of the fluid may be elevated, RBCS appear 
within 2 hours and usually they disappear in about 4 weeks. Indirect van 
den Bergh test may be positive due to the  conversion of oxyHb to 
bilirubin in the first 72 hours. 
Patients who undergo a traumatic tap can easily be differentiated 
from ICH, the CSFobtained from  traumatic tap is usually not completely 
sanguinous and it clots and never shows xanthochromia. The WBC:RBC 
ratio (leucocyte : red cell ratio) in the CSF remains unchanged. 
X-ray Skull, EEGand cerebral angiography are not useful in the 
diagnosis of the infratentorial haematoma, but signs of midline 
displacement in supratentorial lesions can be seen in them. EEG usually 
reveals high voltage, focal or diffuse slow waves in these patients. 
Patients who undergoes radio-isotopic brain scan showsabnormal 
concentrations at the site of the haematoma. CT scan is very helpful in 
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diagnosing, it can reveal the anatomical location, even the dimension of 
the cerebral haematoma. CT scan can also show vascular malformation 
and helpful in excluding other lesions in the brain which mimics 
ganglionic haemorrhage. CT scan is very helpful in defining the 
approachwhen surgical evacuation of the cerebellar haematoma is 
done.But in almost 80% of cases, the diagnosis can be straightforward by 
examination of the CSF, though caution should be exercised because the 
raised intracranial pressure which is seen with haemorrhage can cause 
coning (brainstem herniation into the foramen magnum). MRI is 
definitely superior to CT scan in aiding in diagnosis. In patients with  
arteiovenous malformation, Angiography is done to rule out middle 
cerebral artery aneurysm, and before surgical intervention. 
The ICH is diagnosed by  
 patient presents at the onset with headache, vomiting and nuchal 
rigidity  
 patient do not reveal any prodromal symptoms                                                              
 stroke develops rapidly and no stuttering course is seen                                                 
 patient can present with lethargy which can progress to coma  
 presence of fresh blood in the CSF in HT individualrevealing the 
diagnosis of hypertensive intracerebral haemorrhage. 
 Intracerebral bleed can occur from the ruptured congenital 
aneurysm, or an angioma in persons with high blood pressure  which can 
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only be diagnosed cerebral angiogram. Appropriate blood tests should be 
done to rule out any bleeding disorders such as purpura or leukaemia. 
In patients with pontine haemorrhage and large dissecting haematomas 
the prognosis are usually lethal. Death which occurs in later course of the 
illness may be due to bleeding peptic ulcer of neurogenic origin. The 
patients who have small occult haematomas like thalamic haemorrhage 
and slit haemorrhages, the neurological deficit remains severe and 
unaltered. 
 
Indicators of grave prognosis in ICH are 
 Fever  
 intercurrent infections 
  severe hypertension 
 advanced age 
 uncontrolled diabetes mellitus 
 bleeding diathesis 
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Patients with ICH should be given a general nursing and medical 
care. Patient are usually are treated with parenteral hypotensive agents 
which are needed for rapid  lowering of the high blood pressure. During 
the parenteral Antihypertensive therapy, continuous monitoring of blood 
pressure is mandatory. The role of hypothermia needs to be evaluated. 
When there is evidence of cerebral edema, steroids or oral glycerol 
therapy is indicated, the role of beneficial effects of dexamethasone in the 
treatment of primary intracerebral haemorrhages is controversial. 
The clinical impression in favour of using aminocaproic acid (20 g 
IV 8 hourly) is gaining support, though there are no supportive trials. 
Patients with supratentorial or cerebellar haematoma, surgical 
evacuation should be done to prevent temporal lobe herniation or even 
the compression of the pons, surgical evacuation is usually a life saving 
measure and it should not be delayed. In cerebellar haematoma, surgery 
should be performed before the brainstem is compressed resulting in 
decreased level of consciousness, but clot evacuation may be life-saving 
even in comatose subjects if compression has not been prolonged. 
Moyamoya disease, which is not diagnosed clinically as it is an 
angiographic diagnosis which is characterised by an unusual 
combination of progressive occlusive lesion at the intracranial carotid 
bifurcation with an extensive or profuse abnormal anastomotic network 
of arterioles and capillaries with dilated main arteries at the base of the 
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brain. The characteristic angiographic appearance in these patients is 
usually described as puff of cigarette smoke drifting in the air. These 
patients have carotid occlusion which is a non-inflammatory, and it has 
subintimal fibroplasia near arterial cushion. Moyamoya disease are 
reported in children and young adults among Japanese and other Asians. 
These patients can present with variety of clinical manifestations like 
headache, convulsions and SAH . Till now there is no specific treatment. 
Fibromuscular dysplasiacan also be cause of ICH and it is a 
segmental, non-atheromatous, non-inflammatory angiopathy of 
unknown cause. 
FMD can involve either the intima, media and sometimes even 
the adventitia of renal, aorto-iliac, splenic and internal carotid arteries 
where vascular bruits are present. FMD reveals characteristic 
angiographic appearance, irregular beading stenotic areas alternate with 
pouch dilatation of aneurysmal segments.It is seen in young or middle-
aged women, on oral contraceptive pills, and it may present with 
migraine type headache or TIA. Treatment involves the surgical 
dilatation of the narrowed segments which are helpful in reducing the 
symptoms. Binswanger’s subcortical arteriosclerotic encephalopathy, 
leukoaraiosis, Winiwarter-Buerger disease are some rare causes of 
stroke. 
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Different risk factors have been attributed for strokes in the young 
individuals, hypertension and diabetes mellitus being the most common 
among them. Elevated haematocrit levels (PCV) and disturbed 
equilibrium in coagulation profile and fibrinolysis have been highly 
attributed in the aetiopathology of nonembolic cerebral infarction in the 
young individuals. Patients with stroke, and the possibility of subacute 
central nervous system infections like tuberculosis, syphilis, arteritis and 
autoimmune angiitis as risk factors needs to be evaluated. Ischaemic 
cerebrovascular complications of pregnancy and puerperium are 
commonly seen throughout India, most of the cases are from cerebral 
venous thrombosis occurs during the perinatal period. 
Spontaneous bleeding in the subarachnoid space is known as 
subarachnoid haemorrhage (SAH).SAH usually occurs due to  ruptured 
artery or vein which is called as primary SAH or when it occurs from an 
intracerebral haematoma which dissects through cerebral tissue into the 
ventricles, it is called as secondary SAH. Subarachnoid bleeding occurs 
usually from rupture of a congenital cerebral aneurysm  
  
40 
 
Important causes of SAH are  
 Ruptured aneurysm which can be a 
 congenital 
 mycotic 
 Arteriovenous malformation  
 Intracerebral haemorrhage with extension to subarachnoid space  
 Haemorrhagic cerebral infarction  
 Rupture of atherosclerotic vessel  
 Haemorrhage in a tumour 
 Bleeding disorders, leukaemia, sickle cell anaemia 
 Clotting disorders  
 Vasculitis 
 Infection (TB, syphilis, bacterial)  
 Moyamoya disease  
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 Most of the cerebral aneurysms are found in the anterior half of 
the circle of Willis. Location or cerebral aneurysm occurring most 
frequently are                 
 anterior communicating anterior cerebral junction  
 posterior communicating-internal carotid junction  
 middle cerebral bifurcation  
 intracranial carotid bifurcation  
 vertebro-basilar or basilar bifurcation  
 distal anterior cerebral territory  
A literature which reveals autopsy surveys say that only half the 
aneurysms show evidence of bleeding, whereas an equal number is 
unruptured. A high incidence of PKD and COAhave been seen in 
patients with cerebral aneurysm. 
Usually the media is defective in the branches and bifurcation of 
the cerebral arteries, so, cerebral aneurysms frequently occur in these 
sites. The commonest point of tear is seen in the dome of the aneurysm 
because it is the weakest point of the saccule. These can rupture during 
the episodic raise of blood pressure to alarming heights in normal 
individuals, during violent bouts of coughing or sneezing or heavy 
physical exercise or coitus or emotional excitement, and these incidents 
can occur before a rupture. In the patients in whomthe aneurysm bleeds 
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both within the brain substance and also in the subarachniod space, the 
prognosis is always grave. 
General physical examination of these patientsusually shows no 
abnormality. The blood pressure of these patients are usually within the 
normal range. Some patients may reveal a huge polycystic kidney on 
abdominal examination, while some can show the physical signs of 
coarctation of the aorta  
Some patients with an unruptured aneurysm, which is large and 
firm enough to press on neighbouring structures, can present with visual 
defects, ocular palsies, hypopituitarism or obstructive hydrocephalus. 
These  patients are usually misdiagnosed as brain tumour at initial 
presentation because  the clinical syndrome appears insidiously, until the 
angiography is done which reveals aneurysm. 
While doing physical activity, a "snap" may be heard within the 
head of the patient and the patient may complain a violent headache 
with associated vomiting and sustain a sudden fall on the floor. In 10 per 
cent of cases, seizures are seen at the onset. The symptoms and signs of 
an aneurysm depends on its site, the amount of the bleeding and the time 
of occurrence of Subarachnoid haemorrage. In about 8 per cent of cases 
sudden death from a massive bleed occurs, but in majority of cases i.e. 
about 80 per cent cases awake from the initial coma and they still 
remain confused, disoriented and amnesic for about a week. Intermittent 
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headaches and lethargy are known to occur during this period in these 
patients.                                                                                                                                      
In an anterior communicating rupture, the presentation may be 
transient weakness of both the legs, akinetic mutism with pyramidal 
signs. In a posterior communicating rupture, an ipsilateral third nerve 
palsy is seen. Dilatation of the ipsilateral pupil is an early sign of 
posterior communicating rupture. In the rupture of internal carotid and 
middle cerebral artery aneurysms, a hemiplegic syndrome as described 
under cerebral thrombosis appears. Rapid recovery from a dense 
neurological deficit is highly suggestive of a reflex vasospasm with 
ischaemia of that territory.                       
The common clinical findings in these patients usually includes 
neck rigidity, fever, transient hypertension, pre-retinal haemorrhages, 
restless state with confusion, amnesia with bilateral Babinski’s signs. 
In patients with a massive intraventricular bleed like a basilar 
aneurysm, there are signs like extensor rigidity, irregular respirations 
and bradycardia that accompany the deep coma. Usually death is an 
almost inevitable outcome in these patients. 
Laboratory diagnosis  of subarachnoid hemorrhage is done by the 
examination of CSF examination which reveals  uniformly sanguinous 
CSF under raised pressure and it contains nearly a million RBCs per 
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cumm. CSF examination also reveals the presence of pleocytosis and 
xanthochromia in the patients. 
Cerebral angiography or DSA plays an important role in the 
diagnosis of SAH. It helps to outlines the aneurysm and reveals 
coincident vasospasm or a subdural clot. Serial CT scan should be taken. 
These serial CT s has an important role in diagnosis and helps to tell 
about the prognosis of the patient. Serial CT scan not only reveals the 
subarachnoid haemorrhage, it also shows the aneurysm when taken after 
administration of the contrast. More than 75 per cent of patientsreveals 
SAH bleed on a noncontrast  CT scan which was done within the first 
48 hours of rupture. An MRI scan is superior to CT scan in visualization 
of the aneurysm. In patients with SAH, when ECG was taken it revealed 
the abnormalities which are highly suggestive of myocardial ischaemia, 
when there is no myocardial damage. Hyponatraemia is also seen due to 
the inappropriate secretion of anti-diuretic hormone with volume 
expansion or because of unknown factors which can cause salt and 
water loss with subsequent volume depletion. 
About  8 %  of the individuals die in the first few hours, and 40 % 
die within the next six months due to recurrence. 
Those patients who survive the attack, and who are confused and 
amnesic state,for more than two weeks,indicates a bad prognosis and 
probably it reveals the  irreversible damage and intellectual impairment; 
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and epilepsy can also be seen in these patients. Those patients who 
survive the acute insult show residual disability and are unable to 
resume full work. 
When there is SAH due to rupture of aneurysm or angioma, these 
patients present with excruciating headache and a brief period of 
unconsciousness (collapse) which is usually followed by a lucid interval, 
or a restless state with confusion and disorientation, there is paucity of 
localizing signs, and presence of nuchal rigidity in a normotensive 
individual. Clinically, a close DD is etiologies which causes sudden rise 
of intracranial pressure. Another DD is meningitis when the bleed is 
small. Cerebral angiographic findings are helpful in arriving at the 
diagnosis, but the associated vasospasm may decrease or even prevent 
the visualisation of the malformation aneurysm. 
Treatment of SAH includes absolute bed rest, head end slightly 
elevated, for a period of six weeks. During the acute phase of the illness, 
physical straininglike coughing, sneezing or straining during bowel 
movementhave to be avoided. Patients can be prescribed laxatives. 
Other treatment includes general nursing care and medical care.The 
blood pressure should always be controlled to target levels. Mild 
sedatives or even analgesics can be given for severe headache. Aspirin is 
inappropriate but acetaminophen or meperedine and phenobarbitone are 
given. Heavy sedation has to be prevented as it can cause difficulty in 
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the initial assessment or delayed neurological deficit. Patients can be 
prescribed Chlorpromazine as it sedates the patient and is helpful in 
controlling the nausea and vomiting. Sometimes the seizures can itself 
elevate the blood pressure, and so patients are prescribed anti-
convulsants as prophylaxis measure. The prime objective of the therapy 
is the prevention and treatment of vasospasm. Hypervolaemic therapy is 
useful in increasing the Cerebral Blood Flow during vasospasm. 
Gamma aminocaproic acid and related derivatives like tranexamic 
acid are used in the treatment of SAH and they are of important value to 
reduce the incidence of rebleeding, but some recent studies have shown 
increased risk of cerebral infarction. 
Surgical interventions should be carried out for patients who have 
aneurysms in the accessible territories. The treatment of symptomatic 
vasospasm includes the use of calcium-channel blockers like nimodipine 
(0.7 mg/kg followed by 0.35 mg/kg every 4 hours for 21 days). A 
conservative medical line of treatment should be carried out only when 
the patient has when the aneurysm is in an inaccessible territory or 
aneurysm cannot be visualised or when in presence of systemic diseases 
which are contraindications to surgery. When the patient has severe 
vasospasm, surgery should be postponed. But when the patient presents 
with a subdural bleed or clot, its immediate evacuation is often life-
saving. 
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AHA and ASA have published guidelines for prevention of 
strokes which are helpful in reducing the risk factors associated with 
stroke.
3
 Hypertension is an independent risk factor for stroke.
4
Life style 
modifications include physical activity, obesity management, decreasing 
the salt intake. In the meta-analysis of 23 randomized trials, where the 
patients were put on antihypertensive therapy, and comparision was 
made with patients not put on anymedication. The results were the risk 
of the stroke reduced by 32% in patients with antihypertensives.
5
 When 
the BP was reducd, SBP <140, DBP<90, the risk of cardiovascular 
events decreased. In patients with CKD or DM the target BP is still 
lower i.e. < 130/80 mmHg.
(4)
 
Cigarette smoking has direct link with stroke as it increases the 
risk of both ischemic CVA and SAH, the risk of ischemic stroke doubles 
and risk of SAH increases 2- 4 fold.
(6,7,8,9,10,11)
Smoking increases the 
incidence of Hemorrhagic CVA in young individuals. When smoking is 
quitted after few years, the risk of vascular events in smokers and non 
smokers are almost similar.
(12,13,14,15)
 
Diabetes increases the risk of stroke.
(16)
Statins are helpful in 
reducing the risk of stroke. Role of aspirin in diabetics are yet to be 
established.
(17,18,19)
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Increased level of total cholesterol increases the risk of ischemic 
stroke, revealed in various epidemiological studies.
(20,21,22,23)
The 
National Cholesterol Education Program (NCEP) Adult Treatment Panel 
III (ATP III) have outlined the targets which are helpful to prevent the 
stroke.  
CHAD S2 score is helpful in treating atrial fibrillation 
patients.
(24,25,26,27)
ACTIVE A and ACTIVE W has revealed that warfarin 
at an adjusted dose is superior in the prevention of stroke in patients 
with AF when compared to aspirin and clopidogrel, and when 
clopidogrel with aspirin is used it is superior to aspirin used 
alone.(28)Regular monitoring of INR is necessary in the patients with 
warfarin as it can itself cause ICH. Adjusted-dose warfarin with a target 
of INR 2-3,helps preventing the stroke in patients with AF, and it helps 
to decrease the mortality and severity of stroke. Aspirin is given to 
patients with low risk to prevent stroke. As the LV rejection fraction 
decreases the risk of stroke keeps on increasing. 
A healthy lifestyle includes avoiding smoking, maintaining 
adequate body mass index, involving in regular physical activity, 
adequate intake of vegetables and one study has been linked to  
decreased incidence of total, ischemic, and hemorrhagic stroke when 
patient follows healthy lifestyle. 
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Materials And  
Methods 
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MATERIALS AND METHODS 
Selection criterion: 
 All CVA patients irrespective of their age with CT Findings of 
infarct and hemorrhage. 
Total no. of patients under study- 100 
Period of Study: 
 All the patients admitted as inpatients in Tirunelveli Medical 
College Hospital, during the period of  September2011 – November 2012 
were included in thisstudy. 
Geographic distribution: 
 Geographic distribution of the patients were predominantly from 
rural areas of Tirunelveli, Tenkasi, Tuticorin Districts. 
Exclusion criterion: 
 CVA patients without CT scan 
 Sub arachnoid hemorrhage 
Limitation of the Study: 
 MRI could not be done in all patients because of its  
its cost factor. 
 Echo done only in patients where it was necessary 
 Selection and study of this patients were done as mentioned in 
 the proforma. 
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 All the patients underwent a thorough and detailed history 
regarding onset, activity during stroke and general and neurological 
examinations. 
 Neurological examination was done with reference to motor, 
sensory, autonomic and higher functional disturbances.  
Power is graded according to MRC grading system from 0 to 5.Sensory 
system examinations were done for somatic, special andcortical 
sensation. 
 Higher functions testing were done with minimental scale. 
Clinical assessment of nature of lesion 
Embolic stroke 
 Patients can present with abrupt onset with maximum defecit at 
onset and fast recovery 
 When patient presents with signs of arrhythmias in ECG or 
clinically like AF,SN dysfunction 
 When patient has organic cardiac murmurs 
 When patients presents with signs of heart failure  
 When the patient has a recent h/o MI 
 When echo reveals vegetations which can be due to systemic lupus 
erythematosus , neoplasia, or which can be marantic endocarditis 
 The presence of unequal pulses or BP in limbs suggests the careful 
evaluation of Carotid or vertebrobasilar dissections. 
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 Ischemic infarct in the CT scan with embologenic cardiac lesion 
proved by Echocardiogram 
Hemorrhagic stroke 
 Haemorrhagic stroke is suspected clinically by the presence of 
intense throbbing headache, projectile vomiting, seizures, altered 
sensorium, Neck stiffness, dissociated eye movements, Papilloedema in a 
known hypertensive patients.CT brain revealing hemorrhage                      
(hyperdense). 
Thrombotic stroke 
 Patient presenting with family h/o thrombotic stroke, DM, HT, 
TIA, dyslipidemia. 
 Patient may present with abrupt onset but they evolve somewhat 
more slowly over a period of several minutes or hours and 
occasionally days; in the later case, the stroke usually 
progresses in a step ladder pattern ( in a series of steps). 
 Clinical features vary according to the site of involvement 
 CT brain does not reveal any bleed or hemorrhage 
Time of occurance were divided by the basis: 
 Morning 6 AM –2 PM 
 Noon 2 pm – 10 pm 
 Night 10pm – 6 am 
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Activity during the occurrence of stroke were classified as 
1. Severe activitywhich included hard physical straining like sports 
activity, bicycle riding, sexual intercourse, doing hard physical work 
in sunlight, sporting etc. 
2. Moderate activity includesgrooming, walking, shopping, less strain 
physical activities. 
3. Mild activities like sitting, brushing, conversation, watching 
Telivision, doing benchwork, reading, writing. 
4. Sleep. It also includes when the patient says that when he woke up he 
found himself hemiplegic and before sleep he was absolutely normal. 
5. After careful clinical examination of the patients all the patients  
were submitted to the following investigations. 
I Basic lab investigations: 
a. Urine analysis. 
b. Blood-Sugar, Urea, Creatinine. 
c. Serum electrolytes. 
d. Lipid profile. 
II ECG 
 12 lead ECG was taken atleast once in all those patients. The 
ECG was taken soon after admission and subsequently thereafter if 
needed. 
 Rhythms strips were also taken when required. 
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 Rate, Rhythm, PR interval, QRS axis, QTC interval, ST segment, 
U waves, Ischaemic Changes, chamber hypertrophy were analysed and 
recorded. 
III ECHO 
 The ECHO was done in 18 patients who showed ischaemic and 
other changes in ECG. Special attention was given for any valvular 
dysfunction, reduced LVEF, and any regional wall motion abnormalities. 
IV CT Scan Brain 
 CT Scan Brain was done in all patients included in this study 
within 24 – 48 hrs of admission. It was repeated after 48 hrs when the 
initial CT Scan was negative and also repeated when the patient 
suddenly detoriated or if there is no expected recovery. 
The Imagining of brain was done to 
 To diagnose CVA. 
 To document the presence of haemorrhage or infarct. 
 To locate the site of lesion, size of lesion, extent of brain damage 
and surrounding edema. 
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Results 
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RESULTS AND OBSERVATIONS 
 
Statistical analysis 
 The continuous variables  among the stroke subjects were 
analysed and interpreted according to their stroke type by ANOVA 
(Analysis of Variance) and the difference were interpreted by Bonferroni 
post hoc test. The fasting BGL and PPBGL  was compared by Student’ 
paired ‘t’ test. The Categorical variables were analysed and interpreted 
by χ2 (Chi-square) test. The above statistical procedures were performed 
by statistical package IBM SPSS statistics 20. The P values less than 
0.05 (P<0.05) were considered as significant in two – tail test. 
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I. Age and stroke type distribution  
 The total number of patients included in the study was 100 during 
the period of 2011 – 2012 in Tirunelveli Medical College and Hospital. 
The Age and type of stroke distributions were compiled in tabular 
columns as 
follows: 
Table .1 
Age and stroke type distribution 
Age (years) 
Embolic Hemorrhagic Thrombotic 
Total 
No % No % No % 
<40 0 0.0 1 7.1 1 7.1 2 
40-49 2 25.0 4 28.6 11 14.1 17 
50-59 2 25.0 1 7.1 21 26.9 24 
60-69 1 12.5 5 35.7 31 39.7 37 
70-79 3 37.5 3 21.4 11 14.1 17 
80-89 0 0.0 0 0.0 3 3.8 3 
Total 8 100.0 14 100.0 78 100.0 100 
Mean ± SD 61.1± 14.2 
Range (40to 
79) 
56.6 ±13.0 
 Range (35to 
76) 
59.9±10.9 
Range (21to 
88) 
59.6±11.4 
ANOVA ‘F’ 0.590 
- 
Significance P>0.05 
 The above table 
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II. Age and sex distribution 
 The total number of patients included in the study was 100 during 
the period of 2011 – 2012 in Tirunelveli Medical College and Hospital. 
69 were male and 31 were female patients. 
The Age, Sex distributions were compiled in tabular columns as 
follows: 
Table. 2 
Age and sex distribution 
Sex 
30 - 40 
years 
41- 50 
years 
51- 60 
years 
61 - 70 
years 
71 years 
and above 
Male 2 12 23 21 11 
Female 4 4 7 12 4 
Total 6 16 30 33 15 
 
Total male patients were 69 and female patients were 31 in this 
study. Youngest patient was a male 35 year old and the oldest was a 
female and the patient was 88 years old. Oldest male patient in our study 
was 82 years old. 
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III. Gender wise description of stroke  
Table - 3. 
Genders wise description of stroke. 
Stroke Type 
Genders 
χ
2
 df Signi. 
Male Female Total 
Embolic 5 3 8 
0.726 2 P>0.05 
Hemorrhagic 11 3 14 
Thrombotic 54 24 78 
Total 70 30 100 
  
The gender wise comparison of stroke was shown in the above 
table. There was no significant association between the genders in the 
incidences of stroke (P>0.05). 
8 patients had embolic stroke, 14 patients had hemorrhagic stroke 
and 78 had thrombotic stroke. Out of 8 embolic stroke patients, 5 were 
male patients and 3 were female patients. Out of14 hemorrhagic stroke 
patients, 11 were male patients and 3 were female patients. Out of 78 
thrombotic stroke patients, 54 were male patients and 24 were female 
patients. 
 
 
  
 
 
IV. Significance of risk f
 The type of strokes 
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Hypertension, CAHD, Dys
patient. 
 
54
24
0
10
20
30
40
50
60
thrombotic stroke
62 
actors: 
such as Embolic, Hemorrhagic and Thro
 to any of the risk factors such as Di
lipidemia, Smoking and Alcohol presen
 
 
5
11
3
1.8
embolic stroke hemorrhagic stroke
 
mbotic 
abetic, 
t in the 
male
female
63 
 
 
 
Table - 4 
Comparison of Risk factors  with incidence of stroke. 
 
Stroke Type 
Risk factor 
χ
2
 df Signi. 
Yes No Total 
Embolic 8 0 8 
6.191 2 P<0.05 
Hemorrhagic 14 0 14 
Thrombotic 66 12 78 
Total 88 22 100 
  
  
 The comparison of presence of risk factors with incidence of stroke 
was shown in the above table. There is significant association between 
the presence of risk factors with incidences of stroke (P>0.05). 
 
 
 
 
 
 V. Activity with stroke.
Comparison betw
Activities 
Embolic Hemorr
Mild 4 
Moderate 1 
Severe 1 
Sleeping 2 
Total 8 14
66
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Table-5. 
een activities with incidence of stroke
Stroke Type 
χ
2
 
hagic Thrombotic Total 
4 33 41 
2.401 
3 18 22 
1 6 8 
6 21 29 
 78 100 
8
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VI. Significance of stroke incidence between activity with time 
 
Table - 6. 
Comparison of stroke incidence between Activities with Time. 
 
Activities 
Time 
χ
2
paired df Signi. 
Night 
Other 
time 
Total 
Sleeping 25 4 29 
4.500 1 P<0.05 
Others 
activities 
14 57 71 
Total 39 61 100 
 
 The incidence of strokes during night at sleep was significantly 
more than the incidence of other activities and other Times (P<0.05) 
 VII. Description of the lev
 The biochemical pa
Blood  Glucose,   Cholest
 
Comparison blo
Variable 
Fasting 
Mean SD M
BGL 120.16 39.7 17
  
39
25
67 
el of biochemical parameters:  
rameters such as Fasting Blood Gluco
erol, and TGL. 
Table-7 
od glucose level  of Fasting and PP. 
PP Increase Paired 
‘t’ 
df
ean SD Mean SD 
6.3 65.4 56.1 38.2 14.704 99
39
Time of stroke
 
se, PP 
 Signi 
 P<0.001 
morning time
night time
noon
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 The Fasting BGL and PPBGL were compared in the above table. 
The mean Fasting BGL was 120.16± 39.7 and  mean PPBGL was 
176.3±65.4 . The increased  BGL 56.1±38.2  was statistically very highly 
significant (P<0.001). 
 
 
VIII. Time of stroke with type of stroke 
 
 Morning Noon Night 
Embolic 3 3 2 
Hemorrhagic 3 3 8 
Thrombotic 30 19 29 
 
 36 patients had stroke in the morning. Out of which 3 were 
embolic, 3 were hemorrhagic and 30 were thrombotic. 
 25 patients had stroke in the Noon. Out of which 3 were embolic, 3 
were hemorrhagic and 19 were Thrombotic. 
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DISCUSSION 
 All the 100 patients selected for this study were thoroughly 
examined and the diagnosis of CVA was made clinically and CT Scan 
was taken in all the patients and detailed history regarding the risk 
factors, time of onset of stroke and the activity at the time of stroke were 
obtained. 
 Totally 100 stroke patients were studied, out of which 78 had 
thrombotic stroke, 14 had hemorrhagic stroke and 8 had embolic stroke. 
 Out of 78 thrombotic stroke patients, 30 had stroke in morning, 19 
had stroke in the noon and 29 had stroke in the night .Out of 14 
hemorrhagic stroke patients, 3 had stroke in morning, 3 in the noon and 8 
in the night. 
 Out of 8 embolic stroke patients, 3 had stroke in the morning, 3 had 
stroke in the afternoon and 2 in the night. 
 Thirty-one publications
(29-43)
 were reviewed and the data from the 
meta analysis of these world’s thirty one published studies on the 
circadian timing of stroke onset indicates that, the risk of onset of acute 
stroke is increased during the early morning hours. These data are 
consistent across the various subtypes of stroke like ischemic stroke, 
hemorrhagic stroke and even the transient ischemic attacks, that the 
excess risk during the 6 AM to noon time period is significantly higher 
than would be expected by chance. Similarly, there is a significantly 
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lower risk of stroke during the nighttime hours i.e from midnight to 6 AM 
for each stroke subtype when it was compared with the normalized risk 
for the other 18 hours of the day. There are few reports that division of 
the numbers of strokes according to each of the 24hours of the day, and it 
is possible that these categorization of stroke frequencies into the 
arbitrary time periods for the meta-analysis is incorrect. Previous studies 
regarding time of onset of stroke. 
 
 
Study Year n Population Peak onset 
Hossmann 1971 131 Germany 
1 am to 5 
am 
Marshall 1977 707 England 
Midnight-
6:00 AM 
Agnoli et al 1975 256 France 
6:00 AM-
2:00 PM 
Jovidic 1983 85 Yugoslovakia 
8:00 AM-1 
1:00 AM 
Our study 
2012-
2013 
100 India 
10 PM to 6 
AM 
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 As summarized, results of four studies have been published. Our 
studies correlates with the studies of Marshall and Hossman whose 
studies reveal that the peak of onset of stroke is midnight to 6AM and  
1AM to 5 AM respectively. 
 Our study and several others show that the onset of stroke occurs 
with the hypothesis that onset of the stroke onset coincides with low 
blood pressure, which is well known to occur early in the morning and 
when most people are a sleep.A fall in blood pressure will not lead to the 
fall incerebral blood flow (CBF) when the autoregulation is intact. The 
auto regulation is lost in the patients with  cerebrovascular disease for a 
few days after an acute cerebrovascular episode.  So there is evidence of 
impaired auto regulation in patients with cerebrovascular disease. It can 
also be possible that due to the impairment of vasomotor reflexes, which 
usually develops in the older age group people, the nocturnal fall in blood 
pressure is more profound in these age groups. It is also thought  that 
blood pressure may sometimes fall below the lower limit for auto 
regulation, and thus leading to the fall in cerebral blood flow. 
 The onset of intracerebral hemorrhage and subarachnoid 
hemorrhage are more obviously related to blood pressure. In view to the 
several well known circadian rhythms in the humans, it is not surprising 
that there are several parameters associated with the events that may lead 
to the stroke onset, which has shown to fluctuate with a predictable 
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periodicity. The 24 hour variation in the cortisol secretion is well known 
and this secretion rhythm is not only passively driven by environmental 
events but, it is the product of an endogenous ‘clock’ within the 
organism. 
 Our study reveals that out of 100 stroke patients, 41 had stroke 
during mild activity, 22 had stroke during moderate activity, 8 had stroke 
during vigorous activity and 29 had stroke during sleep. In a study where 
200 patients of ischemic stroke were studied, Koton et al. (44) found an 
approximately 2-fold increased risk of ischemic stroke within 2 hours of 
physical activity that did not reach nominal statistical significance. That 
study did not assess whether the risk is varied by habitual physical 
activity 
 Our study also reveals that the onset of stroke with activity is not 
statistically significant. Our study also does not assess whether this risk 
could be varied by habitual physical activity.  
 Risk factors were evaluated in our study. 43%were hypertensives. 
35 % of the patients had dyslipidemia.25% of the patients were diabetics. 
27% had the h/o CAHD. 37% of the patients were alcoholics. 21% of the 
patients were smokers. 
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Conclusion 
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CONCLUSIONS 
 
1. Our study coincides with the results of studies of Marshall and 
Hossman which says that the onset of stroke is more during night. 
2. Onset of stroke during night is observed in all types of stroke which is 
significant in our study. 
3. The onset of the stroke is not associated with severity of the activity. 
4. Most of the stroke has occurred during mild activity and sleep. 
5. Risk factors evaluated in our study were  
 43% - hypertension 
 37% - alcoholism 
 35% - dyslipidemia 
 27 % - CAHD 
 25% - Diabetes mellitus 
 21 % - smokers 
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PROFORMA 
 
NAME OF THE PATIENT: 
AGE: 
SEX: 
IP NO: 
ADDRESS: 
OCCUPATION: 
TIME OF OCCURANCE OF STROKE: MORNING / NOON / NIGHT 
ACTIVITY AT THE TIME OF STROKE:      
     SLEEP/MILD/MODERATE/SEVERE 
CHIEF COMPLAINTS: 
 
 
HISTORY OF PRESENTING COMPLAINTS: 
 
 
PAST H/O: HT/ DM / TIA/ PTB/ BA/ COPD/ CKD/ CAHD/ RHD/ 
LIVER DISEASE/ SEIZURES/ CVA 
PERSONAL H/O: SMOKING / ALCOHOLISM 
GENERAL EXAMINATION: 
 
 
 
VITALS: BP-                            , PR-                          , RESPIRATORY 
RATE AND PATTERN- 
CLINICAL EXAMINATION- 
CENTRAL NERVOUS SYSTEM- 
 
 
 
 
 
CARDIOVASCULAR SYSTEM: 
RESPIRATORY SYSTEM: 
ABDOMEN: 
SPINE AND CRANIUM: 
CLINICAL DIAGNOSIS: 
INVESTIGATIONS: 
Blood sugar-                        , urea-                   , se creatinine- 
F and PPBS- 
Serum electrolytes: sodium -    , potassium – 
Blood hemogram-                           , TC-                           , DC-                           
, ESR- 
Urine albumin-            , sugar-                , deposits- 
Total cholesterol-                       , TGL – 
ECG- 
Chest xray- 
CT brain – 
MRI brain – 
ECHO- 
FINAL DIAGNOSIS- 
 
 
 
 
Master chart  
 
S.No Ip. No Name Age 
Se
x 
Past h/o Personal h/o Time 
Activity at 
stroke 
Clinical diagnosis CT findings 
F&PP bsugar 
in mg% 
Urea 
Creat 
In 
Mg% 
Tcholes/ TGL 
in mg% 
ECG Cxray Echo Others 
1 
16389 Velsamy 47 M 
DM/ 
CAHD 
Alcoholic/ 
smoker 
noon mild Thrombotic stroke 
Lt MCA &PCA 
infarct 
83/120 
38/ 
0.7 
240/204 
Tinversion 
V5,V6 
cardiomegal
y 
RWMA 
mod 
LV sys 
dysfn, 
grade 2 
diastolic 
dysfn 
 
2 
16299 
Vella 
pandi 
65 M - 
Smoker/ 
alcoholic 
noon severe 
Embolic 
stroke 
Lt MCA 
infarct 
89/ 
115 
21/ 
0.9 
180/ 
118 
Atrial 
fibrillation 
normal -  
3 
25711 Kavitha 40 F HT - night sleep 
Thrombotic 
 
normal 
110 
/145 
22/ 
1 
170/ 
130 
LVH 
strain, 
AL 
ischemia 
cardiomegal
y 
- 
160/90 
mmHG 
4 
14102 Palavesam 72 F 
TIA/ 
Hyper 
thyr 
- morning mild embolic 
RT MCA 
infarct 
112/ 
135 
33/ 
1.1 
190/ 
184 
AF normal - - 
5 
25791 Natarajan 65 m CAHD alcholic morning mild hemorrhagic 
Hemorr 
In lt 
Thalamus 
Inter 
Capsul 
region 
111/ 
143 
24/ 
1.1 
180/142 NSTEMI normal - 
160/100mm
hg 
6 
35104 madasamy 72 m - alcholic noon moderate thrombotic 
Infarct 
Lt mca 
98/119 
29/ 
1.4 
170/ 
114 
Normal normal   
7 
35809 veeravan 67 M HT - night mild thrombotic Infarct in RT MCA 
94/ 
116 
39/ 
1.5 
154/ 
113 
normal normal   
8. 
35161 senthil 35 M - alcoholi night sleep Hemorrhagic stroke 
Hemorrhageinrt 
ventricle 
131/ 
292 
3/1.2 
289/ 
212 
n n   
9. 
33124 kathirvel 60 m - Smoke/alc night sleep thrombotic 
Infarct in ltparieto 
Occipital region 
97/ 
160 
40/ 
1.4 
180/ 
146 
n n   
10. 
35187 mohamed 76 m HT - noon moderate Hemorrhagic stroke 
Left 
Frontal 
Hemorr 
hage 
118/ 
207 
40/ 
1.5 
165/ 
130 
n n   
11. 
24186 annathai 65 f 
HT/ 
TIA 
 morning moderate thrombotic 
Rt MCA 
infarct 
113/ 
193 
32/ 
1.3 
294/ 
212 
n n   
12 
65836 sarvanan 70 m HT/ alc noon mild Hemorrhagic stroke 
Hemorrhage in 
Lt fronto 
108/ 
178 
39/ 
1.4 
190/ 
134 
n n  
200/ 
100 
Parietal 
area 
mmHG 
13 
67165 ram 70 m 
HT/ 
DM 
Alcoholic 
smoker 
night moderate thrombotic Infarct LT mca 
180/ 
298 
35/ 
1.4 
312/ 
243 
LVH 
strain 
n  
160/90 
mmhG 
14 
60600 
Booda 
than 
60 m HT 
Alcoholic 
smoker 
night sleep hemorrhagic Hemorrhage in rtmca 
112/ 
166 
40/ 
1.5 
198/ 
115 
LVH 
cardiomegal
y 
 200/110 
15 
40355 sitaram 50 M  alcoholic morning mild thrombotic 
Multiple infarct in rt 
cerebral hemisphere 
97/ 
160 
35/ 
1.4 
188/ 
115 
n n   
16 
30355 thiruvengadam 45 m - alcoholic noon mild Thrombotic 
Multiple infarct in rt 
Cerebral hemisphere 
112/ 
145 
40/ 
1.4 
190/ 
144 
n n   
17. 
59550 armugam 59 m HT 
Alcoholic 
smoker 
night sleep thrombotic Rtmca infarct 
122/ 
149 
39/1 
189/ 
137 
LVH 
Cardiomegal
y 
  
18 
37705 avudayammal 80 f 
Ht/ 
DM 
 night sleep thrombotic Lt mca 
189/ 
222 
33/ 
1.5 
312/ 
276 
Inferior 
wall 
ischemia 
n   
19 
68466 nagarajan 62 m 
HT/ 
DM 
smoker morning mild thrombotic Rtmca 120/177 28/0.5 
288/ 
212 
n n   
20 
38466 thirumani 63 m HT alcoholic noon mild thrombotic Rtmca 110/167 30/1 
198/ 
146 
LVH n   
21 
75836 sankaran 66 m 
HT/ 
DM 
Alcoholic 
smoker 
night sleep hemorrhagic 
Hemorrhage in ltmca 
 
 
190/ 
248 
33/ 
1.2 
292/ 
226 
LVH n  
 
 
 
22 
66222 meenakshi 66 f 
HT/ 
DM 
 noon sleep thrombotic Rtmca 
140/ 
201 
34/ 
1.3 
288/ 
205 
n n   
23 
213234 sundar 48 m - alcoholic morning mild embolic Rtmca infarct 
112/ 
144 
33/ 
1.3 
188/ 
134 
Atrial 
fibrillation 
n   
24 
24442 rani 40 f CAD  noon sleep embolic Lt mca infarct 
121/ 
177 
39/ 
1.5 
198/ 
113 
Atrial 
fibrillation 
n 
Severe 
MS/ 
LAE+/pht 
 
25. 
214232 kani 45 f -  morning  thrombotic Rtmca infarct 
120/ 
165 
37/ 
1.4 
188/ 
112 
n n n  
26 
234543 shyam 48 m - alcohlic noon severe thrombotic rtmca infarct 
112/ 
198 
40/ 
1 
323/246 n n   
27 
213423 ibrahim 50 m - - noon mild thrombotic Lt mca infarct 
121/ 
199 
39/ 
1.4 
345/ 
243 
n n   
28 
312021 kavitha 70 f  DM morning severe hemorrhagic 
Hemorrhage in 
Rtparieto occipital 
area 
214/344 
40/ 
1.6 
332/ 
286 
n n  
200/ 
110mm 
Hg 
29 
213423 arun 60 m - - night sleep hemorrhagic 
Hemorrhage in 
Rt frontal area 
210/ 
334 
40/1.5 
312/ 
268 
n n  
180/130 
mmhg 
30 
214234 rahim 73 m - HT night mild Thrombotic 
Lt mca 
infarct 
112/ 
154 
20/0.7 
169/ 
112 
LVH n   
31 
214341 mahima 60 f - DM noon moderate thrombotic Rtmca infarct 
212/ 
300 
33/ 
1 
241/ 
195 
n n   
32 
312293 ravi 77 m - DM morning moderate thrombotic 
Lt mca 
infarct 
232/ 
336 
40 
1 
212/ 
189 
n n   
33 
49015 savier 56 m 
Smoker 
alcholic 
CAHD noon moderate thrombotic 
Lt mca 
infarct 
112/ 
145 
34 
1.4 
298/ 
212 
Old asmi n   
34 
25836 rasammal 70 f  HT/DM night sleep thrombotic 
Lt mca 
infarct 
240/523 40/1 
312/ 
200 
n n   
35 
37165 ponnusamy 82 m alcoholic  noon moderate thrombotic 
Lt mca 
infarct 
121/ 
192 
33/ 
1.3 
170/ 
143 
LVH 
strain,infer
ior wall 
ischemia 
n   
36 
58430 mariamal 60 f  HT/DM night sleep thrombotic 
rtmca 
infarct 
189/ 
280 
32/ 
1.4 
243/ 
179 
n n   
37 
55836 rajendran 69 m  HT/DM night sleep thrombotic 
ltmca 
infarct 
199/ 
290 
33/1.3 
256/ 
180 
n n   
38 
68430 
shanmugavadi
vu 
58 F  HT morning MILD thrombotic Rtmca infarct 
110/ 
140 
32/ 
1.3 
298/ 
234 
n n   
39 
35891 natarajan 41 m 
Smoker/ 
alch 
 noon moderate hemorrhagic 
Rt ICH with 
intraventricularext 
121/ 
198 
29/ 
1.5 
187/ 
150 
n n   
40 
58447 selvi 67 f  HT/DM night sleep thrombotic Rtmca infarct 
180/ 
240 
33/ 
1.4 
198/ 
144 
n n   
41 
42490 sudali 60 f  HT morning mild thrombotic Lt mca infarct 
111/ 
144 
39/ 
1.2 
162/ 
136 
n n   
42 
43953 utthandu 50 m   morning mild thrombotic Rtmca infarct 
112/ 
155 
28/ 
1.2 
156/ 
111 
n n   
43 
43903 nellaippan 70 m   morning mild thrombotic Lt mca infarct 
113/ 
144 
33/ 
1.4 
166/ 
122 
n n   
44 
42653 durai 75 m alcoholic  mornigng mild thrombotic Lt mca infarct 
103/ 
124 
33/ 
1.4 
228/ 
198 
n n   
45 
41467 vadivelu 21 m 
Smoker/ 
alch 
 night mild thrombotic Lt mca infarct 
103/ 
149 
33/ 
1.5 
160/ 
122 
n n   
46 
42708 iyanal 65 f   noon moderate thrombotic Lt mca infarct 
103/ 
155 
33/ 
1.5 
232/ 
217 
Lateral 
wall 
ischemia 
n   
47 
42705 parvathi 88 f   noon mild thrombotic Lt mca infarct 
113/ 
144 
33/ 
1.4 
166/ 
122 
n n   
48 
42687 sornavadivu 75 f  HT/DM morning mild thrombotic Lt mca infarct 
78/ 
135 
38/ 
1.4 
145/ 
122 
n n   
49 
43997 perumal 74 m   night sleep thrombotic High parietal infarct 85/114 
34/ 
1.3 
154/ 
122 
n n   
50 63162 hariharan 56 m  CAHD night sleep thrombotic Rtmca infarct 88/ 38/ 150/ n n   
113 1.4 120 
51 
54361 kandasamy 67 M  CAHD night sleep thrombotic Lt mca infarct 
91/ 
112 
40/ 
1.4 
152/ 
122 
n n   
52 41572 viswanathan 58 m  CAHD night sleep thrombotic Lt mca INFARCT 90/125 33/0.9 160/130 N N   
53 64105 selvarajan 61 m Smoking CAHD/ morning moderate thrombotic Lt mca infarct 80/140 30/0.8 140/110 n n   
54 
53521 murugesan 73 m 
Smoking/Alcoh
olism 
CAHD/ orning mild thrombotic Lt mca infarct 89/133 33/1.0 150/113 n n   
55 36431 nakulan 53 m  HT night Sleep thrombotic Rtmca infarct 82/150 32/0.8 170/110 n n   
56 35413 vijayaraghavan 48 m  HT/DM morning moderate thrombotic Lt mca infarct 97/160 33/0.9 156/134 n n   
57 33514 manoharan 55 m  CAHD/DM night mild thrombotic rtmca infarct 110/180 31/1.0 160/126 n n   
58 38156 dhinakaran 68 m Alcoholic CAHD/ morning mild thromotic Lt mc infarct 85/140 42/0.8 150/113 n n   
59 32501 gunasekaran 61 m  HT morning mild thrombotic rtmca infarct 84/150 50/0.8 170/123 n n   
60 32506 gunasankaran 62 m alcholic HT morning mild thrombotic Rtmca infarct 85/150 40/0.9 143/112 n n   
61 
73721 
Saraswatiamm
al 
61 f  HT/DM night sleep thrombotic Lt mca infarct 99/180 36/1.5 180/154 n n   
62 41575 murugan 60 m  HT/Alcohol morning severe thrombotic Lt mca infarct 85/150 31/0.8 173/124 n n   
63 32568 manimaran 62 m  CAHD/DM morning moderate thrombotic Lt mca infarct 96/164 32/0.8 200/173 n n   
64 35512 dharmalingam 65 M  CAHD night mild thrombotic normal 89/112 39/1.4 165/112 n n   
65 
63125 kartik 61 m alcoholic CAHD night sleep thrombotic normal 81/141 40/.8 
152/ 
112 
n n   
66 
64332 gunasekar 59 m  CAHD/DM night moderate embolic Rtmca infarct 82/112 34/1.3 154/112 
Atrial 
fibrillation 
cardiomegal
y 
  
67 
46122 gopalan 72 m alcoholic CAHD/DM morning mild thrombotic Lt mca infarct 181/241 40/.8 
212/ 
112 
Old awmi n   
68 
49586 kalidasan 52 m 
Smoking/alcoh
ol 
 night sleep thrombotic normal 89/112 39/1.4 165/112 n n   
69 
43758 vasanth 56 n 
Smoking/alcoh
ol 
CAHD morning moderate thrombotic normal 81/141 40/.8 
152/ 
112 
Old IWMI n   
70 
51523 meenakshi 55 f  CAHD night sleep thrombotic Lt mca infarct 96/164 32/0.8 200/173 
Old 
AWMI 
n   
71 
41532 ravikumar 60 m  HT night mild thrombotic Rtmca infarct 
88/ 
118 
40/1.5 177/145 LVH n   
72 
61108 
Kumara 
shankar 
65 m alcoholism CAHD morning moderate thrombotic Lt mca infarct 111/141 40/1.4 150/112 N n   
73 25438 kuppusamy 53 m alcoholism CAHD morning moderate thrombotic Lt mca infarct 114/145 40/1.4 140/102 N n   
74 
53254 mujibeer 59 M  
DM/HT/CAH
D 
morning moderate thrombotic Rtmca infarct 
180/ 
243 
38/ 
1.6 
212/ 
188 
Old awmi n   
75 
26858 ramalingam 53 M 
Smoking/alcoh
olism 
CAHD night sleep thrombotic Lt mcainfarct 111/178 40/1.3 156/112 Old IWMI n   
76. 
21615 
sivasubramani
an 
59 M  CAHD noon severe thrombotic Rtmca infarct 112/163 39/1.2 154/117 
Old 
AWMI 
n   
77 35462 dhanabalan 56 M  CAHD morning severe thrombotic Lt mca infarct 110/154 40/1.2 150/124 Old IWMI n   
78 
28017 Abdul 79 M smoking CAHD noon mild embolic Rtmca infarct 112/145 41/1.5 152/112 
Atrial 
fibrillation
/IWMI 
cardiomegal
y 
  
79 
28481 sundar 76 m 
Smoking/alcoh
olism 
CAHD morning mild embolic 
Rt MCA with PCA, 
watershed zone infarct 
212/312 40/.7 170/134 
Multiple 
VPCs 
cardiomegal
y 
Mild LV 
systolic 
dysfn, 
large LV 
apical clot 
 
80 28292 thangavel 53 m  CKD night sleep hemorrhagic Lt ICH 70/112 138/7.6 212/190 normal n   
81 29860 lakshmi 65 f  HT noon mild thrombotic normal 72/119 21/0.6 150/88 n n   
82 65332 muthu 55 m alcoholism  night severe thrombotic Lt mca infarct 112/145 41/1.5 152/112 n n   
83 35421 ramnath 45 m alcoholism - noon mild thrombotic normal 72/119 23/0.6 150/89 n n   
84 45231 kannan 47 m smoking HT morning mild thrombotic Rtmca infarct 112/145 41/1.5 152/112 n n   
85 87768 ramakrishnan 63 m  HT morning severe thrombotic Lt mca infarct 108/145 42/1 152/115 n n   
86 
25480 esaki 60 M 
Smoking/alcoh
ol 
HT morning mild thrombotic Rtmca infarct 112/150 36/1.2 144/112 
Inferior 
wall 
ischemia 
n   
87 
25521 anwar 60 M 
Smoking/alcoh
ol 
HT/CKD noon mild thrombotic 
Rt MCA with PCA, 
watershed zone infarct 
116/166 110/7 198/186 Lvh strain n   
88 
23539 karupaiya 64 m  HT/ckd/dm night mild hemorrhagic 
Hemorrhage in rt 
parietal lobe 
121/189 96/4 196/158 
LVH 
strain 
n   
89 
29195 sudalai 45 m 
Smoking/alcoh
ol 
HT night sleep hemorrhagic 
RT ICH with dilated 
ventricle with midline 
shift 
121/154 44/1.3 176/110 LVH n   
90 
45841 kalaiselvi 47 f  HT morning moderate hemorrhagic RT ICH 121/154 44/1.3 176/110 
Sinus 
bradycardi
a 
n   
91 58430 vadivukani 58 f  HT morning mild thrombotic Rtmca infarct 112/145 23/.5 298/232 n n   
92 56232 valli 65 f  DM/HT noon sleep thrombotic Rtmca infarct 200/288 23/.6 288/254 n n   
93 39105 kavya 56 f   night moderate thrombotic Lt mca infarct 112/188 24/0.7 144/115 n n   
94 
47615 bhavana 50 f  CAHD night sleep embolic Rtaca infarct 102/165 32/.8 150/112 AF n 
Lv 
systolic 
dysfuncti
on,LV 
clot 
 
  
 
 
 
 
 
 
 
95 
48625 ramnya 40 f  HT night mild hemorrhagic 
ICH with 
intraventricular 
extension 
82/178 28/0.7 164/125 n n   
96 37619 suganya 66 f   noon sleep thrombotic Rtaca infarct 92/150 28/1 144/115 n n   
97 27915 muthu 62 f   night moderate thrombotic Lt mca infarct 91/148 24/1.7 286/215 n n   
98 17676 praba 42 f   noon moderate thrombotic Rtmca infarct 112/188 24/1.1 294/245 n n   
99 17915 vasantha 40 f  DM night mild thrombotic Lt mca infarct 151/208 24/0.6 299/202 n n   
100 17421 ravi 40 M smoker HT night mild thrombotic Rtmca infarct 102/135 23/1 122/144 n n   
